Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.10
Bid: 8.70
Ask: 9.50
Change: -0.15 (-1.62%)
Spread: 0.80 (9.195%)
Open: 9.25
High: 9.25
Low: 9.10
Prev. Close: 9.25
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Apr 2018 12:43

RNS Number : 8024L
Scancell Holdings Plc
23 April 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

SCANCELL HOLDINGS PLC

 

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

X

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Hygea vct plc

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

18 April 2018

6. Date on which issuer notified (DD/MM/YYYY):

20 April 2018

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.5%

0%

3.5%

374,469,098

Position of previous notification (if

applicable)

4.2%

 

 

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

13,149,730

 

3.5%

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

 

 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Hygea vct plc

3.5%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

     

 

Place of completion

London, England

Date of completion

18 April 2018

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVLSDIVFIT
Date   Source Headline
8th Oct 201210:31 amRNSNotice of Results and Share Price Movement
3rd Oct 20123:30 pmRNSChange of Advisers
10th Sep 201211:10 amRNSHolding(s) in Company
3rd Sep 20125:39 pmRNSHolding(s) in Company
23rd Aug 20127:00 amRNSHolding(s) in Company
20th Aug 20124:03 pmRNSHolding(s) in Company
20th Aug 20124:01 pmRNSMarket Update
17th Aug 20129:24 amRNSHolding(s) in Company
15th Aug 20121:12 pmRNSModitope Vaccine Technology Platform
19th Jun 20127:00 amRNSLong Term Treatment Approval
25th May 20127:00 amRNSVesting of Ichor Options
2nd May 20127:00 amRNSSCIB1 Update
17th Apr 20127:00 amRNSSCIB1 Trial Update
16th Apr 201211:34 amRNSHolding(s) in Company
13th Mar 20128:23 amRNSNotice of Investor Meeting
9th Mar 20127:00 amRNSPatent Approval
29th Feb 20123:49 pmRNSChange of Registered Office
31st Jan 20127:00 amRNSHalf Year Results
13th Dec 20114:28 pmPRNIssue of Equity
17th Nov 201111:29 amPRNHoldings in Company
4th Nov 20117:00 amPRNConfirmation of GBP2.85 million payment
25th Oct 20117:00 amPRNProgress on possible GBP2.85m payment
19th Aug 201112:25 pmPRNHolding(s) in Company
18th Aug 201111:37 amPRNAppointment of Director
17th Aug 20117:00 amPRNSCIB1: Safety Review and Dose Escalation
26th Jul 20111:01 pmPRNHolding(s) in Company
25th Jul 201112:45 pmPRNAGM & EGM Statement
30th Jun 201111:48 amPRNChange of Board Structure
30th Jun 201111:46 amPRNDevelopment of new vaccine for treating lung cancer
30th Jun 201111:44 amPRNPlacing to raise £1.73 million
30th Jun 201111:37 amPRNFinal Results
3rd Jun 20117:00 amPRNAppointment of Broker
31st Jan 20118:30 amPRNInterim Results
31st Jan 20117:00 amPRNSCIB1: Safety Review and Dose Escalation
28th Jan 20117:00 amPRNRe: SCIB1 Clinical Trial Patient Recruitment
13th Jan 20117:00 amPRNIssue of Equity
14th Dec 20102:25 pmPRNResult of AGM
14th Dec 20107:00 amPRNAGM Statement
7th Sep 201011:00 amPRNRe: ImmuneRegen Strategic Collaboration
6th Sep 20107:00 amPRNAppointment of Broker
10th Aug 20107:00 amPRNLicence Agreement with Cancer Research Technology

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.